Condensed Statement of Cash Flows (Unaudited) - USD ($)	8 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2021
Cash flows from operating activities
Net loss		$ (3,323,722)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
General and administrative expenses paid by related party		806,724
Interest income on investments held in Trust Account		(14,385)
Changes in fair value of warrant liability		(2,071,893)
Changes in fair value of forward purchase securities liability		2,055,630
Changes in operating assets and liabilities:
Other assets		361,537
Accrued expenses		2,095,044
Payables to related party		(37,640)
Franchise tax payable		145,455
Deferred offering costs associated with proposed initial public offering		131,695
Net cash provided by operating activities		148,445
Cash flows from investing activities
Cash deposited to Trust Account		(250,000,000)
Net cash used in investing activities		(250,000,000)
Cash flows from financing activities
Proceeds from issuance of Class B common stock	25,000
Proceeds from related party – Sponsor loan		1,197,223
Proceeds received from initial public offering		250,000,000
Proceeds received from private placement		6,000,000
Offering costs paid		(5,393,362)
Payment of related party payable		(1,952,306)
Net cash provided by financing activities	25,000	249,851,555
Net change in cash	25,000
Cash - beginning of the period		25,000
Cash - end of the period	25,000	25,000
Supplemental disclosure of non-cash financing activities:
Offering costs paid with note payable to Sponsor		91,750
Changes in fair value of warrant liability		2,071,893
Changes in fair value of forward purchase securities liability		(2,055,630)
Prepaid expenses paid with payables to related party		$ 997,137